NYSE:FMS - Fresenius Medical Care AG & Co. Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Get Started
$50.55 +0.21 (+0.42 %)
(As of 06/20/2018 04:00 PM ET)
Previous Close$50.55
Today's Range$50.18 - $50.57
52-Week Range$44.88 - $57.94
Volume88,881 shs
Average Volume146,222 shs
Market Capitalization$30.86 billion
P/E Ratio22.87
Dividend Yield0.85%
Beta0.62
Fresenius Medical Care AG & Co. logoFresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S. for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist and intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; and offers non-dialysis products, including acute cardiopulmonary and apheresis products. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2017, it operated 3,752 outpatient dialysis clinics in approximately 50 countries. The company has operations in Germany, the United States, and internationally. Fresenius Medical Care AG & Co. KGaA was founded in 1996 and is headquartered in Bad Homburg, Germany.

Receive FMS News and Ratings via Email

Sign-up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
SymbolNYSE:FMS
CUSIPN/A
Webwww.freseniusmedicalcare.com
Phone49-6172-6090

Debt

Debt-to-Equity Ratio0.53
Current Ratio1.26
Quick Ratio1.01

Price-To-Earnings

Trailing P/E Ratio22.87
Forward P/E Ratio19.22
P/E Growth2.73

Sales & Book Value

Annual Sales$20.09 billion
Price / Sales1.54
Cash Flow$3.5902 per share
Price / Cash14.08
Book Value$19.97 per share
Price / Book2.53

Profitability

EPS (Most Recent Fiscal Year)$2.21
Net Income$1.45 billion
Net Margins7.29%
Return on Equity11.09%
Return on Assets4.92%

Miscellaneous

Employees114,000
Outstanding Shares612,900,000

Fresenius Medical Care AG & Co. (NYSE:FMS) Frequently Asked Questions

What is Fresenius Medical Care AG & Co.'s stock symbol?

Fresenius Medical Care AG & Co. trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."

How often does Fresenius Medical Care AG & Co. pay dividends? What is the dividend yield for Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. declared an annual dividend on Thursday, May 10th. Shareholders of record on Tuesday, May 22nd will be paid a dividend of $0.436 per share on Monday, June 4th. This represents a yield of 0.86%. The ex-dividend date is Monday, May 21st. View Fresenius Medical Care AG & Co.'s Dividend History.

How were Fresenius Medical Care AG & Co.'s earnings last quarter?

Fresenius Medical Care AG & Co. (NYSE:FMS) announced its earnings results on Thursday, May, 3rd. The company reported $0.49 earnings per share for the quarter, missing analysts' consensus estimates of $0.70 by $0.21. The company had revenue of $3.98 billion for the quarter, compared to analyst estimates of $4.07 billion. Fresenius Medical Care AG & Co. had a return on equity of 11.09% and a net margin of 7.29%. The firm's revenue was down 12.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.01 earnings per share. View Fresenius Medical Care AG & Co.'s Earnings History.

When is Fresenius Medical Care AG & Co.'s next earnings date?

Fresenius Medical Care AG & Co. is scheduled to release their next quarterly earnings announcement on Tuesday, August, 7th 2018. View Earnings Estimates for Fresenius Medical Care AG & Co..

What price target have analysts set for FMS?

7 brokerages have issued twelve-month price objectives for Fresenius Medical Care AG & Co.'s stock. Their predictions range from $44.00 to $62.00. On average, they expect Fresenius Medical Care AG & Co.'s stock price to reach $53.00 in the next year. View Analyst Ratings for Fresenius Medical Care AG & Co..

Who are some of Fresenius Medical Care AG & Co.'s key competitors?

Who are Fresenius Medical Care AG & Co.'s key executives?

Fresenius Medical Care AG & Co.'s management team includes the folowing people:
  • Mr. Robert Maurice Powell Jr., Chairman of the Mgmt Board & CEO of Fresenius Medical Care Mgmt AG (Age 63)
  • Mr. Michael Brosnan, CFO & Member of the Mgmt Board at Fresenius Medical Care Mgmt AG (Age 63)
  • Mr. Kent Wanzek, CEO of Global Mfg & Quality & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 59)
  • Dr. Olaf Schermeier, CEO of Global R&D and Member of the Mgmt Board - Fresenius Medical Care Mgmt AG (Age 46)
  • Mr. Harry de Wit, CEO of APAC & Member of Mgmt Board - Fresenius Medical Care Mgmt AG (Age 56)

Has Fresenius Medical Care AG & Co. been receiving favorable news coverage?

News coverage about FMS stock has been trending somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Fresenius Medical Care AG & Co. earned a media sentiment score of 0.09 on Accern's scale. They also assigned news stories about the company an impact score of 46.40 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are Fresenius Medical Care AG & Co.'s major shareholders?

Fresenius Medical Care AG & Co.'s stock is owned by many different of institutional and retail investors. Top institutional shareholders include Northern Trust Corp (0.13%), Royal Bank of Canada (0.10%), Thornburg Investment Management Inc. (0.06%), US Bancorp DE (0.05%), Allianz Asset Management GmbH (0.05%) and Allianz Asset Management GmbH (0.05%). View Institutional Ownership Trends for Fresenius Medical Care AG & Co..

Which major investors are selling Fresenius Medical Care AG & Co. stock?

FMS stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Boston Partners, US Bancorp DE, Bbva Compass Bancshares Inc., Allianz Asset Management GmbH, Allianz Asset Management GmbH, A.R.T. Advisors LLC and Intrust Bank NA. View Insider Buying and Selling for Fresenius Medical Care AG & Co..

Which major investors are buying Fresenius Medical Care AG & Co. stock?

FMS stock was purchased by a variety of institutional investors in the last quarter, including Thornburg Investment Management Inc., Millennium Management LLC, Sivik Global Healthcare LLC, Royal Bank of Canada, Barclays PLC, Wells Fargo & Company MN, Aperio Group LLC and Northern Trust Corp. View Insider Buying and Selling for Fresenius Medical Care AG & Co..

How do I buy shares of Fresenius Medical Care AG & Co.?

Shares of FMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Fresenius Medical Care AG & Co.'s stock price today?

One share of FMS stock can currently be purchased for approximately $50.55.

How big of a company is Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co. has a market capitalization of $30.86 billion and generates $20.09 billion in revenue each year. The company earns $1.45 billion in net income (profit) each year or $2.21 on an earnings per share basis. Fresenius Medical Care AG & Co. employs 114,000 workers across the globe.

How can I contact Fresenius Medical Care AG & Co.?

Fresenius Medical Care AG & Co.'s mailing address is ELSE-KROENER STRASSE 1, BAD HOMBURG 2M, 61352. The company can be reached via phone at 49-6172-6090 or via email at [email protected]


MarketBeat Community Rating for Fresenius Medical Care AG & Co. (FMS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  226 (Vote Outperform)
Underperform Votes:  334 (Vote Underperform)
Total Votes:  560
MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care AG & Co. and other stocks. Vote "Outperform" if you believe FMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.